PsilOCD: A Pharmacological-Challenge Feasibility Study

Clinical trial NCT06258031 · COMPLETED

Trial details

NCT number: NCT06258031
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2022-10-28
Primary completion: 2024-06-28
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.